Monday, 08 August, 2016

    Insomnia Treatment Market Faces Steep Decline to 2016, but New Drugs Will Aid Recovery

    Insomnia drug sales will fall rapidly from $2.1 billion in 2013 to $1.4 billion by 2016, before steadily recovering to $1.8 billion by 2023, driven by


    Category:
    No Comment
    Tags: sunovion dainippon sumitomo's lunesta (eszopiclone)